ABVC BIOPHARMA, INC. (ECOC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 400K 800K 1.2M Q1 '11: 7.2K Q2 '11: 4.3K Q3 '11: 3.2K Q4 '11: 2.8K Q1 '12: 5.7K Q2 '12: 5.7K Q3 '12: 5.7K Q4 '12: 10.7K Q1 '13: 7.8K Q2 '13: 7.8K Q3 '13: 7.8K Q4 '13: 761 Q1 '14: 0 Q2 '14: 0 Q3 '14: 0 Q3 '15: 3.4K Q1 '19: 219.2K Q2 '19: 407.8K Q3 '19: 604.7K Q4 '19: 701.7K Q1 '20: 568.3K Q2 '20: 603K Q3 '20: 520.8K Q4 '20: 483K Q1 '21: 667.4K Q2 '21: 472.3K Q3 '21: 455.8K Q4 '22: 969.8K Q1 '23: 1.1M Q2 '23: 765.6K Q3 '23: 739.3K Q4 '23: 152.4K Q1 '24: 25.4K Q2 '24: 136.4K Q3 '24: 509.8K Q4 '24: 509.6K Q1 '11 Q2 '12 Q3 '13 Q3 '15 Q1 '20 Q2 '21 Q3 '23 Q4 '24

Gross Profit TTM

-250K 0 250K 500K 750K Q4 '16: 70K Q4 '18: -178.3K Q1 '19: 32.4K Q2 '19: 209.9K Q3 '19: 404.7K Q4 '19: 681.6K Q1 '20: 545.7K Q2 '20: 589.5K Q3 '20: 501.5K Q4 '20: 464.3K Q1 '21: 651.4K Q2 '21: 459.9K Q3 '21: 451.6K Q4 '22: 683.4K Q1 '23: 727.6K Q2 '23: 356.3K Q3 '23: 311K Q4 '23: -149.6K Q1 '24: -216.7K Q2 '24: -32.9K Q3 '24: 369.8K Q4 '24: 508.8K Q4 '16 Q2 '19 Q1 '20 Q4 '20 Q3 '21 Q2 '23 Q1 '24 Q4 '24

Operating Income TTM

-21M -14M -7M 0 7M 14M 21M Q1 '11: -1.4M Q2 '11: -1.8M Q3 '11: -1.9M Q4 '11: -2M Q1 '12: -2M Q2 '12: -1.5M Q3 '12: -1.1M Q4 '12: -821.5K Q1 '13: -511.4K Q2 '13: -285.3K Q3 '13: -177.3K Q4 '13: -39.8K Q1 '14: -19.4K Q2 '14: -70 Q3 '16: -11M Q4 '16: -7.8M Q1 '17: -1.4M Q2 '17: -1.3M Q3 '17: -4M Q4 '17: -4.1M Q1 '18: -4.6M Q2 '18: -4.9M Q3 '18: -1.9M Q4 '18: -2.8M Q1 '19: -2.8M Q2 '19: -2.8M Q3 '19: -3.5M Q4 '19: -3.5M Q1 '20: -3.9M Q2 '20: -4.6M Q3 '20: -4.8M Q4 '20: -8.5M Q1 '21: -8.6M Q2 '21: -9.4M Q3 '21: -10.1M Q4 '21: -11.7M Q1 '22: -16.7M Q2 '22: -16.7M Q3 '22: -18.4M Q4 '22: -15.1M Q1 '23: -10.8M Q2 '23: -10.9M Q3 '23: -9.4M Q4 '23: -6.8M Q1 '24: -7.7M Q2 '24: -6.4M Q3 '24: -4.5M Q4 '24: -4.7M Q1 '25: -2.6M Q2 '25: -4M Q3 '25: -5.7M Q4 '25: -7.2M Q1 '26: -8M Q2 '26: -6.5M Q1 '12 Q4 '13 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Net Income TTM

-21M -14M -7M 0 7M 14M 21M Q1 '11: -527.8K Q2 '11: -1.1M Q3 '11: -1.2M Q4 '11: -1.1M Q1 '12: -1.9M Q2 '12: -1.3M Q3 '12: -1.1M Q4 '12: -946.2K Q1 '13: -707.7K Q2 '13: -552.3K Q3 '13: -361.6K Q4 '13: -207.8K Q1 '14: -103.6K Q2 '14: -70 Q3 '14: -70 Q3 '15: -32.3K Q4 '15: -3.5M Q1 '16: -10.1M Q2 '16: -10.4M Q3 '16: -11.1M Q4 '16: -7.8M Q1 '17: -1.4M Q2 '17: -1.3M Q3 '17: -4.1M Q4 '17: -4.2M Q1 '18: -4.7M Q2 '18: -5.2M Q3 '18: -2.5M Q4 '18: -6.1M Q1 '19: -6.2M Q2 '19: -6.1M Q3 '19: -6.7M Q4 '19: -3.9M Q1 '20: -4.4M Q2 '20: -5.9M Q3 '20: -6.7M Q4 '20: -10.6M Q1 '21: -10.5M Q2 '21: -10.3M Q3 '21: -9.9M Q4 '21: -12.9M Q1 '22: -17.7M Q2 '22: -17.6M Q3 '22: -19.5M Q4 '22: -16.4M Q1 '23: -12.3M Q2 '23: -12.7M Q3 '23: -12.3M Q4 '23: -7.8M Q1 '24: -8.8M Q2 '24: -7.5M Q3 '24: -4.6M Q4 '24: -4.9M Q1 '25: -2.9M Q2 '25: -4.2M Q3 '25: -5.9M Q4 '25: -7.9M Q1 '26: -8.6M Q2 '26: -7.1M Q3 '11 Q3 '13 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Cost of Revenue TTM

0 150K 300K 450K Q1 '19: 186.8K Q2 '19: 197.8K Q3 '19: 200.1K Q4 '19: 20.1K Q1 '20: 22.6K Q2 '20: 13.5K Q3 '20: 19.3K Q4 '20: 18.7K Q1 '21: 16K Q2 '21: 12.4K Q3 '21: 4.2K Q4 '21: 5.1K Q1 '22: 5.7K Q2 '22: 13.5K Q3 '22: 23.8K Q4 '22: 286.4K Q1 '23: 344.8K Q2 '23: 409.4K Q3 '23: 428.2K Q4 '23: 302K Q1 '24: 242.1K Q2 '24: 169.3K Q3 '24: 140K Q4 '24: 763 Q3 '19 Q2 '20 Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24

Operating Cash Flow TTM

-12M -8M -4M 0 4M 8M 12M Q2 '11: -1.5M Q3 '11: -1.6M Q4 '11: -1.8M Q1 '12: -1.2M Q2 '12: -1.1M Q3 '12: -915.1K Q4 '12: -584.8K Q1 '13: -370.4K Q2 '13: -131.9K Q3 '13: -37.8K Q4 '13: -1.4K Q1 '14: -210 Q2 '14: -70 Q3 '14: 1.2K Q3 '15: 3.4K Q4 '15: -870.9K Q1 '16: -425.5K Q2 '16: -3.3M Q3 '16: -3.5M Q4 '16: -2.8M Q1 '17: -4.1M Q2 '17: -1.5M Q3 '17: -1.6M Q4 '17: -1.5M Q1 '18: -1.2M Q2 '18: -1.4M Q3 '18: -1.3M Q4 '18: -900.5K Q1 '19: -974.5K Q2 '19: -1.3M Q3 '19: -1.4M Q4 '19: -3.1M Q1 '20: -3.2M Q2 '20: -3.8M Q3 '20: -3.9M Q4 '20: -4.6M Q1 '21: -5.3M Q2 '21: -5.4M Q3 '21: -7.3M Q4 '21: -7.6M Q1 '22: -9.2M Q2 '22: -11.2M Q3 '22: -9.5M Q4 '22: -7.4M Q1 '23: -5.9M Q2 '23: -3.4M Q3 '23: -4.2M Q4 '23: -4.2M Q1 '24: -3.6M Q2 '24: -3M Q3 '24: -1.5M Q4 '24: -1.8M Q1 '25: -1.4M Q2 '25: -2.1M Q3 '25: -3.1M Q4 '25: -3M Q1 '26: -3.3M Q2 '26: -2.7M Q3 '11 Q3 '13 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow TTM

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q3 '12: -915.5K Q4 '12: -584.8K Q1 '13: -370.4K Q2 '13: -131.9K Q3 '13: -37.8K Q3 '22: -9.6M Q4 '22: -7.5M Q3 '12 Q4 '12 Q1 '13 Q2 '13 Q3 '13 Q3 '22 Q4 '22

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 80M 160M 240M Q2 '10: 6.6M Q4 '10: 6.9M Q1 '11: 10.2M Q2 '11: 10.7M Q4 '11: 16.1M Q1 '12: 16.3M Q2 '12: 28.9M Q4 '14: 54.6M Q4 '15: 163.9M Q4 '16: 210.8M Q1 '17: 212.1M Q2 '17: 213.7M Q3 '17: 213.7M Q4 '17: 213.7M Q1 '18: 11.6M Q2 '18: 11.6M Q3 '18: 213.9M Q1 '19: 15M Q2 '19: 17.4M Q3 '20: 19.5M Q1 '21: 24.4M Q2 '21: 24.4M Q3 '21: 26.9M Q1 '22: 29.7M Q2 '22: 3.1M Q3 '22: 3.3M Q1 '23: 3.3M Q2 '23: 3.3M Q3 '23: 4.1M Q1 '24: 9.7M Q2 '24: 11.3M Q3 '24: 12.4M Q1 '25: 15M Q2 '25: 17.4M Q3 '25: 23.3M Q1 '26: 25.4M Q2 '26: 26.1M Q4 '10 Q2 '12 Q2 '17 Q3 '18 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q1 '11: -0.25 Q2 '11: -0.32 Q3 '11: -0.31 Q4 '11: -0.27 Q1 '12: -0.23 Q2 '12: -0.13 Q3 '13: 0.00 Q4 '13: 0.00 Q1 '14: 0.00 Q2 '14: 0.00 Q3 '14: -0.01 Q3 '15: -0.01 Q4 '15: -0.03 Q1 '16: -0.06 Q2 '16: -0.06 Q3 '16: -0.06 Q4 '16: -0.04 Q1 '17: -0.01 Q2 '17: -0.01 Q3 '17: -0.02 Q4 '17: -0.02 Q1 '18: -0.07 Q2 '18: -0.12 Q3 '18: -0.10 Q4 '18: -0.40 Q1 '19: -0.40 Q2 '19: -0.38 Q3 '19: -0.46 Q4 '19: -0.22 Q1 '20: -0.23 Q2 '20: -0.29 Q3 '20: -0.30 Q4 '20: -0.49 Q1 '21: -0.48 Q2 '21: -0.47 Q3 '21: -0.45 Q4 '21: -0.51 Q1 '22: -0.66 Q2 '22: -1.17 Q3 '22: -2.24 Q4 '22: -3.41 Q1 '23: -3.76 Q2 '23: -3.85 Q3 '23: -3.53 Q4 '23: -1.80 Q1 '24: -1.54 Q2 '24: -0.94 Q3 '24: -0.15 Q4 '24: -0.45 Q1 '25: -0.22 Q2 '25: -0.27 Q3 '25: -0.33 Q4 '25: -0.39 Q1 '26: -0.39 Q2 '26: -0.29 Q2 '12 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.